Exercise Behaviors and Fatigue in Patients Receiving Immunotherapy for Advanced Melanoma: A Cross-Sectional Survey via Social Media

Integrative Cancer Therapies
Amelia HyattDonna Milne

Abstract

Objective: Treatment with immunotherapy has positively changed the long-term outlook of many patients with advanced melanoma; however, fatigue is a common and debilitating side effect. Evidence indicates exercise can improve treatment-related fatigue for patients receiving chemotherapy and radiotherapy. However, currently little is known about exercise behaviors and preferences of patients receiving immunotherapy. This project aimed to describe self-reported levels of fatigue related to immunotherapy; patient perspectives of exercise behaviors; and barriers and facilitators to engagement in exercise for patients receiving, or recently completed immunotherapy for unresectable stage III and stage IV melanoma. Method: A cross-sectional purpose-built survey was distributed to members of the Melanoma Patients Australia closed Facebook group via an online survey platform. The survey remained active for 1 month, with 3 posts during this time inviting members to participate. Results: A total of 55 responses were collected. Just over half the participants (n = 31; 56%) described exercising while receiving immunotherapy, with walking as the most common activity (n = 24; 77%). Participants described a range of physical and emotional benef...Continue Reading

References

Apr 13, 2005·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Kerry S CourneyaAdrian S Fairey
Mar 19, 2008·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Kerry S CourneyaRoanne J Segal
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Sep 24, 2013·Lancet·Alexander M M EggermontCaroline Robert
Jan 24, 2016·Journal of Psychosomatic Research·Julie M CessnaPaul B Jacobsen
Jun 15, 2016·European Journal of Cancer Care·N García-RuedaM Arantzamendi Solabarrieta
Oct 23, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C FranklinD Schadendorf
Jan 10, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberCaroline Robert
Feb 12, 2017·The Breast : Official Journal of the European Society of Mastology·Andrea LipsettAnita O'Donovan
Feb 17, 2017·The American Journal of Bioethics : AJOB·Luke GelinasBarbara E Bierer
Apr 15, 2017·Critical Care : the Official Journal of the Critical Care Forum·Frank KroschinskyUNKNOWN Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group
Apr 30, 2017·Epidemiologic Reviews·Prue CormieKathryn H Schmitz
Sep 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sarah J Hardcastle, Paul A Cohen
May 3, 2018·The Medical Journal of Australia·Prue CormieDiana Adams
Apr 19, 2019·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu

❮ Previous
Next ❯

Citations

Apr 3, 2020·International Journal of Molecular Sciences·Vera PetrovaViktor Umansky
Jul 3, 2021·Future Oncology·Ann TiveyRebecca J Lee

❮ Previous
Next ❯

Software Mentioned

MPA
Pilates
Excel
SurveyMonkey

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.